Skip to Content
Morningstar

Organogenesis Holdings Inc Class A ORGO

Morningstar Rating
Unlock
Stock XNAS Rating as of
$2.29 −0.70 (23.32%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

View History
ORGO is trading at a 42% discount.
Price
$2.97
Fair Value
$8.59
Uncertainty
Very High
1-Star Price
$9.38
5-Star Price
$6.65
Economic Moat
Hgjq
Capital Allocation
—
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ORGO is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$2.98
Day Range
$2.17–2.95
52-Week Range
$1.80–4.71
Bid/Ask
$2.25 / $2.34
Market Cap
$301.54 Mil
Volume/Avg
2.6 Mil / 863,876

Key Statistics

Price/Earnings (Normalized)
23.10
Price/Sales
0.70
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
862
Website
https://www.organogenesis.com

Comparables

Valuation

View More
Metric
ORGO
MMSI
MDXG
Price/Earnings (Normalized)
 23.1024.3867.70
Price/Book Value
 1.083.536.59
Price/Sales
 0.703.412.92
Price/Cash Flow
 6.1919.9017.59
Price/Earnings
ORGO
MMSI
MDXG

Financial Strength

Metric
ORGO
MMSI
MDXG
Quick Ratio
 2.313.812.95
Current Ratio
 2.805.453.57
Interest Coverage
 5.758.075.74
Quick Ratio
ORGO
MMSI
MDXG

Profitability

Metric
ORGO
MMSI
MDXG
Return on Assets (Normalized)
 2.79%9.43%12.48%
Return on Equity (Normalized)
 4.67%14.77%123.45%
Return on Invested Capital (Normalized)
 3.65%11.47%42.32%
Return on Assets
ORGO
MMSI
MDXG
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRFyrvxsfdcFstnkc$69.8 Bil
ZTS
Zoetis Inc Class AYmpzkfyqFndkc$68.9 Bil
HLN
Haleon PLC ADRTkshgpjHntw$37.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVvgklbkyTvfm$14.8 Bil
VTRS
Viatris IncNfktshbfDzhl$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRSpbgggbVkbxm$11.9 Bil
CTLT
Catalent IncJtyrbflcCjtxndg$10.1 Bil
PRGO
Perrigo Co PLCRjlvnxqsMgn$4.2 Bil
CURLF
Curaleaf Holdings IncCzqcpjldwWpms$3.6 Bil
PBH
Prestige Consumer Healthcare IncLmydgyvdPnvmwy$3.5 Bil

Sponsor Center